Board approves 1:1 bonus, Rs 7 interim dividend and RSU 2025

Results RestatedResults View source PDF Explain this filing

LALPATHLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.6%Reaction day

₹1545.00

prior close

₹1570.00

announcement price

In-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-0.6%+2.2% vs market

Healthcare Service Provider peers, median of 22sector+0.0%+1.6% vs sector

On the reaction day the stock moved 2.2 pts more than Nifty Smallcap 250 and 1.6 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

+0.5

15m

+1.3

30m

+0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.6-0.6+2.2+0.0+1.6

Next day

+5.1+0.1+5.0+0.0+5.1

+2.4-0.5+3.0+0.0+2.4

+0.8-2.0+2.8-2.3+3.1

+0.3-2.2+2.5-3.0+3.3

-0.2-2.3+2.0-0.4+0.2

-0.2-1.7+1.5-0.2+0.1

15d

+0.9-4.6+5.5-1.6+2.6

-1.0-3.7+2.7-5.8+4.8

-4.0-4.2+0.2-7.2+3.2

-7.8-10.9+3.2-14.2+6.4

UpDownMarket · Nifty Smallcap 250Sector · Healthcare Service Provider peers, median of 22Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved Q2 and H1 FY26 results, reviewed by the auditor with no modification. It declared a second interim dividend of Rs 7 per share (record date November 7). A 1:1 bonus of 8.38 crore shares, from securities premium, needs approval. RSU 2025 permits up to 5,27,403 shares at face-value exercise price, vesting in 1-4 years, from the ESOP 2022 reserve. Standalone comparatives were restated. Authorized capital goes to Rs 200 crore.

Likely market impact

The dividend and bonus support shareholder returns, but the bonus adds no value. RSU 2025 dilution is about 0.3 percent. Approval is pending.